CG Oncology, Inc. Common stock (CGON) has a market capitalization of $5.68B and trades at $67.28. The 52-week range is 14.8-69.35.
Key metrics include a trailing Price-to-Earnings (P/E) ratio of -32.3, Earnings Per Share (EPS) of $-2.08, annual revenue of $4.04M.
The stock has a beta of 0.71, operates in the Healthcare sector.
